...
The truth is that Pfizer didn’t receive any funding from Operation Warp Speed for the development, clinical trial and manufacturing of the vaccine. Rather, its partner, BioNTech SE, has received money -- from the German government.
...
Berlin gave the German company $445 million in an agreement in September to help accelerate the vaccine by building out manufacturing and development capacity in its home market.
...
事实是,辉瑞公司没有从Warp Speed行动获得任何资金来进行疫苗的开发,临床试验和生产。 相反,其合作伙伴BioNTech SE已从德国政府获得了款项。
...
柏林在9月的一项协议中向德国公司(BioNTech SE)提供了4.45亿美元,以通过在其本国市场上建立制造和开发能力来帮助加速疫苗的生产。
...